Human Organoids Market

The report "Human Organoids Market by Product (Liver, Kidney, Pancreatic Models (2D, 3D)), Disease Area (Oncology, GI, Neurological Disorders), Application (Drug Toxicity, Personalized Medicine), End User (Pharma & Biotech Companies, CROs) - Global Forecast to 2029", is valued at an estimated USD  1.19 billion in 2024 and is projected to reach USD  2.33 billion by 2029 at a CAGR of 14.4% during the forecast period.

Browse 543 market data Tables and 51 Figures spread through 426 Pages and in-depth TOC on "Human Organoids Market by Product (Liver, Kidney, Pancreatic Models (2D, 3D)), Disease Area (Oncology, GI, Neurological Disorders), Application (Drug Toxicity, Personalized Medicine), End User (Pharma & Biotech Companies, CROs) - Global Forecast to 2029"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/human-liver-model-market-171046468.html

The human organoids market is expanding due to the need to reduce animal testing in research is growing, and organoids can be seen as a particularly ethical alternative that resonates with both public and scientific interests. Organoids have the capacity to provide early-stage data that is much more reliable in the drug development process. This means that research costs can be reduced, enabling early identification of effective compounds which translates to fewer costly failures at the later stages of research. Additionally, advancements are being driven by the increasing interest and investments of both the public and private sectors in organoid research. Along with the increasing incidence of cancers and infectious diseases, the need for organoids to examine the condition is increasing and thus adding to the human organoids market. Besides drug testing and disease modeling, organoids are being applied in many other fields such as regenerative medicine, toxicology testing, and personalized therapies.

In 2023, the largest culture method segment of the human organoids market was Matrigel Matrix Culture.

Categorized by culture method, the human organoids market is segmented into matrigel matrix culture, air-liquid interface culture, suspension culture, 3D bioprinting culture and other culture methods. The largest share of human organoids market was held by the matrigel matrix culture in 2023. Matrigel has the largest share in the human organoids market, mainly because of its unique properties that allow easy growth and differentiation of organoids. Secondly, it is easy to prepare and use, researchers can use it comfortably while compatibility with large number and spectrum of cell types can be applied for many other purposes such as in organoids model across several different kinds of organs such as intestines, liver, or brain. These factors cumulatively have led to the wide acceptance and adoption of Matrigel into the varied research practices, which firmly solidified the market position.

In 2023, the oncology segment dominated the human organoids market by disease area segment.

Based on the disease area, the market is divided into oncology, liver diseases, gastrointestinal diseases, cardiovascular diseases, infectious diseases, neurological disorders, and other disease areas.

The human organoids oncology segment captured the largest share of the market, mainly driven by the rising global cancer prevalence. Organoids have been crucial for advancing research and therapy strategies for cancer, using models very similar to the patient tumors. It is also crucial for personalized precision medicine, allowing the testing of therapies specifically tailored to individual patient profiles. This helps make treatment much more effective and results in fewer side effects, and thus the organoids oncology segment is a great market to be centered on.

North America is the largest regional market for human organoids market.

The market for human organoids has been segmented into five primary geographical regions, that include North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2023, the North America region held the dominant share of the human organoids market.. The human organoids market in North America is the biggest regional market, mainly due to the fact that developed healthcare systems prevail in this region, such as in the US and Canada. Significant spending on health care further allows the region to engage intensely in research and innovation in biomedical technologies like that in organoids. High prevalence of infections and cancers in North America have raised the need for better research tools that can improve understanding and treatment of such diseases. Therefore, an augmented robust healthcare infrastructure, increased funding towards research, and a resultant pressing demand for effective therapies propel North America toward a significant position in the global human organoids market.

The major players operating in this market are Thermo Fisher Scientific Inc. (US), Corning Incorporated (US), Merck KGaA (Germany),  BioIVT (US), HUB Organoids BV (Netherland), BICO (Sweden), BeCytes Biotechnologies SL (Spain), InSphero (Switzerland), GBA Group (Germany), and Kirkstall ltd. (UK).

Don’t miss out on business opportunities in Human Organoids Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]